{"count": 250, "results": [{"_id": "33198356", "pmid": 33198356, "pmcid": "PMC7698147", "title": "Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review", "journal": "Int J Mol Sci", "authors": ["Ahn HK", "Lee YH", "Koo KC"], "date": "2020-11-12T00:00:00Z", "doi": "10.3390/ijms21228540", "meta_date_publication": "2020 Nov 12", "meta_volume": "21", "meta_issue": "22", "meta_pages": "", "score": 50275.812, "text_hl": "Current Status and Application of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ for @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@Prostate Cancer@@@: A Comprehensive Review", "citations": {"NLM": "Ahn HK, Lee YH, Koo KC. Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review Int J Mol Sci. 2020 Nov 12;21(22):. PMID: 33198356", "BibTeX": "@article{33198356, title={Current Status and Application of Metformin for Prostate Cancer: A Comprehensive Review}, author={Ahn HK and Lee YH and Koo KC}, journal={Int J Mol Sci}, volume={21}, number={22}}"}}, {"_id": "40639382", "pmid": 40639382, "title": "Metformin in prostate cancer.", "journal": "Lancet Oncol", "authors": ["Gebrael G", "Chehade CH", "Agarwal N"], "date": "2025-08-01T00:00:00Z", "doi": "10.1016/S1470-2045(25)00291-8", "meta_date_publication": "2025 Aug", "meta_volume": "26", "meta_issue": "8", "meta_pages": "982-983", "score": 50275.414, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@.", "citations": {"NLM": "Gebrael G, Chehade CH, Agarwal N. Metformin in prostate cancer. Lancet Oncol. 2025 Aug;26(8):982-983. PMID: 40639382", "BibTeX": "@article{40639382, title={Metformin in prostate cancer.}, author={Gebrael G and Chehade CH and Agarwal N}, journal={Lancet Oncol}, volume={26}, number={8}, pages={982-983}}"}}, {"_id": "36175875", "pmid": 36175875, "pmcid": "PMC9520831", "title": "Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells", "journal": "BMC Cancer", "authors": ["Olokpa E", "Mandape SN", "Pratap S", "Stewart MV"], "date": "2022-09-29T00:00:00Z", "doi": "10.1186/s12885-022-10115-3", "meta_date_publication": "2022 Sep 29", "meta_volume": "22", "meta_issue": "1", "meta_pages": "1025", "score": 50273.492, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ regulates multiple signaling pathways within castration-resistant @SPECIES_9606 @@@human@@@ @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@ cells", "citations": {"NLM": "Olokpa E, Mandape SN, Pratap S, Stewart MV. Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells BMC Cancer. 2022 Sep 29;22(1):1025. PMID: 36175875", "BibTeX": "@article{36175875, title={Metformin regulates multiple signaling pathways within castration-resistant human prostate cancer cells}, author={Olokpa E and Mandape SN and Pratap S and Stewart MV}, journal={BMC Cancer}, volume={22}, number={1}, pages={1025}}"}}, {"_id": "37409095", "pmid": 37409095, "pmcid": "PMC10318334", "title": "A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways", "journal": "Prostate Int", "authors": ["Kim Y", "Yoo S", "Lim B", "Hong JH", "Kwak C", "You D", "Hwang JJ", "Kim CS"], "date": "2023-06-01T00:00:00Z", "doi": "10.1016/j.prnil.2022.11.003", "meta_date_publication": "2023 Jun", "meta_volume": "11", "meta_issue": "2", "meta_pages": "83-90", "score": 50272.96, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ has potential as an anticancer drug for @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@PCa@@@, with several currently ongoing clinical trials evaluating @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@'s role as an anticancer agent. ", "citations": {"NLM": "Kim Y, Yoo S, Lim B, Hong JH, Kwak C, You D, Hwang JJ, Kim CS. A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways Prostate Int. 2023 Jun;11(2):83-90. PMID: 37409095", "BibTeX": "@article{37409095, title={A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways}, author={Kim Y and Yoo S and Lim B and Hong JH and Kwak C and You D and Hwang JJ and Kim CS}, journal={Prostate Int}, volume={11}, number={2}, pages={83-90}}"}}, {"_id": "36178848", "pmid": 36178848, "pmcid": "PMC9742285", "title": "Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population-based study Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: a population-based study", "journal": "Prostate", "authors": ["Lee YHA", "Hui JMH", "Chan JSK", "Liu K", "Dee EC", "Ng K", "Tang P", "Tse G", "Ng CF"], "date": "2023-01-01T00:00:00Z", "doi": "10.1002/pros.24443", "meta_date_publication": "2023 Jan", "meta_volume": "83", "meta_issue": "1", "meta_pages": "119-127", "score": 50270.93, "text_hl": "However, it is unclear whether the survival benefits associated with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use in @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@PCa@@@ is applicable to ADT. ", "citations": {"NLM": "Lee YHA, Hui JMH, Chan JSK, Liu K, Dee EC, Ng K, Tang P, Tse G, Ng CF. Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population-based study Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: a population-based study Prostate. 2023 Jan;83(1):119-127. PMID: 36178848", "BibTeX": "@article{36178848, title={Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: A population-based study Metformin use and mortality in Asian, diabetic patients with prostate cancer on androgen deprivation therapy: a population-based study}, author={Lee YHA and Hui JMH and Chan JSK and Liu K and Dee EC and Ng K and Tang P and Tse G and Ng CF}, journal={Prostate}, volume={83}, number={1}, pages={119-127}}"}}, {"_id": "32035002", "pmid": 32035002, "pmcid": "PMC7131852", "title": "Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer", "journal": "Cancer Med", "authors": ["Tan XL", "E JY", "Lin Y", "Rebbeck TR", "Lu SE", "Shang M", "Kelly WK", "D'Amico A", "Stein MN", "Zhang L", "Jang TL", "Kim IY", "Demissie K", "Ferrari A", "Lu-Yao G"], "date": "2020-04-01T00:00:00Z", "doi": "10.1002/cam4.2862", "meta_date_publication": "2020 Apr", "meta_volume": "9", "meta_issue": "7", "meta_pages": "2379-2389", "score": 50268.27, "text_hl": "Individual and joint effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and statins on mortality among @SPECIES_9606 @@@patients@@@ with high-risk @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@", "citations": {"NLM": "Tan XL, E JY, Lin Y, Rebbeck TR, Lu SE, Shang M, Kelly WK, D'Amico A, Stein MN, Zhang L, Jang TL, Kim IY, Demissie K, Ferrari A, Lu-Yao G. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer Cancer Med. 2020 Apr;9(7):2379-2389. PMID: 32035002", "BibTeX": "@article{32035002, title={Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer}, author={Tan XL and E JY and Lin Y and Rebbeck TR and Lu SE and Shang M and Kelly WK and D'Amico A and Stein MN and Zhang L and Jang TL and Kim IY and Demissie K and Ferrari A and Lu-Yao G}, journal={Cancer Med}, volume={9}, number={7}, pages={2379-2389}}"}}, {"_id": "34399755", "pmid": 34399755, "pmcid": "PMC8369631", "title": "Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway", "journal": "Cancer Cell Int", "authors": ["Chen C", "Wang H", "Geng X", "Zhang D", "Zhu Z", "Zhang G", "Hou J"], "date": "2021-08-17T00:00:00Z", "doi": "10.1186/s12935-021-02043-2", "meta_date_publication": "2021 Aug 17", "meta_volume": "21", "meta_issue": "1", "meta_pages": "404", "score": 50267.684, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ exerts anti-AR-negative @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@ activity via @GENE_PRKAA1 @GENE_5562 @@@AMPK@@@/autophagy signaling pathway", "citations": {"NLM": "Chen C, Wang H, Geng X, Zhang D, Zhu Z, Zhang G, Hou J. Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway Cancer Cell Int. 2021 Aug 17;21(1):404. PMID: 34399755", "BibTeX": "@article{34399755, title={Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway}, author={Chen C and Wang H and Geng X and Zhang D and Zhu Z and Zhang G and Hou J}, journal={Cancer Cell Int}, volume={21}, number={1}, pages={404}}"}}, {"_id": "36744171", "pmid": 36744171, "pmcid": "PMC9896090", "title": "A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer", "journal": "Clin Med Insights Oncol", "authors": ["Lee CS", "Lam SY", "Liu A", "Sison C", "Zhu XH"], "date": "2023-02-01T00:00:00Z", "doi": "10.1177/11795549231152073", "meta_date_publication": "2023", "meta_volume": "17", "meta_issue": "", "meta_pages": "11795549231152073", "score": 50265.207, "text_hl": "A Retrospective Study of the Effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @SPECIES_9606 @@@Patients@@@ with @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@Metastatic Prostate Cancer@@@", "citations": {"NLM": "Lee CS, Lam SY, Liu A, Sison C, Zhu XH. A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer Clin Med Insights Oncol. 2023;17():11795549231152073. PMID: 36744171", "BibTeX": "@article{36744171, title={A Retrospective Study of the Effect of Metformin on Patients with Metastatic Prostate Cancer}, author={Lee CS and Lam SY and Liu A and Sison C and Zhu XH}, journal={Clin Med Insights Oncol}, volume={17}, pages={11795549231152073}}"}}, {"_id": "33831975", "pmid": 33831975, "pmcid": "PMC8761231", "title": "The Effect of Metformin on Male Reproductive Function and Prostate: An Updated Review", "journal": "World J Mens Health", "authors": ["Tseng CH"], "date": "2022-01-01T00:00:00Z", "doi": "10.5534/wjmh.210001", "meta_date_publication": "2022 Jan", "meta_volume": "40", "meta_issue": "1", "meta_pages": "11-29", "score": 50264.914, "text_hl": "Many clinical trials are being conducted to investigate the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ as an adjuvant therapy for @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@PCa@@@ but results currently available are not conclusive. ", "citations": {"NLM": "Tseng CH. The Effect of Metformin on Male Reproductive Function and Prostate: An Updated Review World J Mens Health. 2022 Jan;40(1):11-29. PMID: 33831975", "BibTeX": "@article{33831975, title={The Effect of Metformin on Male Reproductive Function and Prostate: An Updated Review}, author={Tseng CH}, journal={World J Mens Health}, volume={40}, number={1}, pages={11-29}}"}}, {"_id": "34660791", "pmid": 34660791, "pmcid": "PMC8519697", "title": "The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis", "journal": "Biomed Res Int", "authors": ["Yao X", "Liu H", "Xu H"], "date": "2021-10-08T00:00:00Z", "doi": "10.1155/2021/5311828", "meta_date_publication": "2021", "meta_volume": "2021", "meta_issue": "", "meta_pages": "5311828", "score": 50263.055, "text_hl": "Therefore, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ was likely to be an effective adjuvant, especially in @<m>DISEASE_Prostatic_Neoplasms</m> @DISEASE_MESH:D011471 @@@prostate cancer@@@.", "citations": {"NLM": "Yao X, Liu H, Xu H. The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis Biomed Res Int. 2021;2021():5311828. PMID: 34660791", "BibTeX": "@article{34660791, title={The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis}, author={Yao X and Liu H and Xu H}, journal={Biomed Res Int}, volume={2021}, pages={5311828}}"}}]}